It seems that there is no content provided for summarization. Please provide the text you would like me to summarize.
NVO has been in the news recently: Novo Nordisk warned that 2026 sales and profit would decline, forecasting sales to fall 5–13% (versus an estimated -1.39%). The guidance shocked investors and sent its U.S. shares plunging—reports cited drops of about 13–18%—leaving the stock roughly 64% below mid‑2024 highs.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.